Pharmacoeconomic evaluation of testing for angiotensinconverting enzyme genotype before starting ß-hydrocy-ß-methylglutaryl coenzyme A reductase inhibitor therapy in men

Maitland-van der Zee, A.H.; Klungel, O.H.; Stricker, B.H.Ch.; Veenstra, D.L.; Kastelein, J.J.P.; Hofman, A.; Witteman, J.C.M.; Leufkens, H.G.M.; van Duijn, C.M.; de Boer, A.

Pharmacoeconomic evaluation of testing for angiotensinconverting enzyme genotype before starting ß-hydrocy-ß-methylglutaryl coenzyme A reductase inhibitor therapy in men

DSpace/Manakin Repository

Pharmacoeconomic evaluation of testing for angiotensinconverting enzyme genotype before starting ß-hydrocy-ß-methylglutaryl coenzyme A reductase inhibitor therapy in men

Maitland-van der Zee, A.H.; Klungel, O.H.; Stricker, B.H.Ch.; Veenstra, D.L.; Kastelein, J.J.P.; Hofman, A.; Witteman, J.C.M.; Leufkens, H.G.M.; van Duijn, C.M.; de Boer, A.

(2004) Pharmacogenetics, volume 14, pp. 53 - 60

(Article)

Download/Full Text

Open Access version via Utrecht University Repository

Unknown

Keywords: Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health

ISSN: 0960-314X

Publisher: Lippincott Williams and Wilkins

(Peer reviewed)

See more statistics about this item